Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
出版年份 2014 全文链接
标题
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
作者
关键词
-
出版物
BLOOD
Volume 124, Issue 25, Pages 3748-3757
出版商
American Society of Hematology
发表日期
2014-10-16
DOI
10.1182/blood-2014-05-576116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma
- (2013) Lu Zhang et al. CANCER LETTERS
- Hypoxia inducible factor pathway inhibitors as anticancer therapeutics
- (2013) Sarah K Burroughs et al. Future Medicinal Chemistry
- Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells
- (2013) Hiroko Tadokoro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
- (2013) P Storti et al. LEUKEMIA
- The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis
- (2013) K A Kocemba et al. LEUKEMIA
- MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer
- (2013) Weiyun Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients
- (2013) Song Xu et al. PLoS One
- MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
- (2013) Ching-Wen Lin et al. Nature Communications
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Hypoxic enhancement of exosome release by breast cancer cells
- (2012) Hamish W King et al. BMC CANCER
- Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
- (2012) J. Hu et al. Disease Models & Mechanisms
- Leukemia cell to endothelial cell communication via exosomal miRNAs
- (2012) T Umezu et al. ONCOGENE
- Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders
- (2012) S Yoshizawa et al. Blood Cancer Journal
- miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma
- (2011) H. Matsuyama et al. BLOOD
- Biological aspects of angiogenesis in multiple myeloma
- (2011) Eléonore Otjacques et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
- (2011) S K Martin et al. LEUKEMIA
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of relapsed and refractory multiple myeloma in the era of novel agents
- (2010) Niels W.C.J. van de Donk et al. CANCER TREATMENT REVIEWS
- The use of novel agents in the treatment of relapsed and refractory multiple myeloma
- (2009) J P Laubach et al. LEUKEMIA
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
- (2008) M. Bache et al. CURRENT MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now